Nintendo Co plans to begin assembly of its new Switch as soon as July and release the upgraded replacement for its four-year-old game console in September or October, people familiar with the matter said.
The new console, likely to be priced higher than the US$299 original, might be announced ahead of the E3 conference starting on June 12 to allow publishers to showcase their full range of Switch games at the global event, the people said, asking not to be named because the plans are not yet public.
It would be sold alongside the US$199 Switch Lite, with the standard Switch phased out over time.
Assemblers would start shipping the new model — whose commercial name is known only to a handful of people within the Kyoto-based company — as early as July, with production expected to ramp up to a peak in the October-December quarter.
This is despite widespread semiconductor shortages that have affected the supply of everything from automobiles to TVs, headphones and games consoles, including the Switch itself.
Suppliers are confident they can fulfill Nintendo’s orders, despite the ongoing chip shortages. Its production lines are better prepared for the potential component shakeup and the parts Nintendo is using are subject to less competition than those in its rivals’ more powerful consoles.
Still, the company’s ability to meet consumer demand would not be guaranteed, as a dearth of display driver ICs and Bluetooth chips have led to production of the incumbent Switch stopping and starting several times, the people said.
Nintendo president Shuntaro Furukawa said at its earnings conference earlier this month that demand for the Switch remains high and the company was not able to produce as many units as it wanted.
Pricier components and rising labor costs in China are likely to push up the new Switch’s price from the US$299 that the console has been at since its launch in March 2017.
Although the final retail price is not yet known, suppliers expect their per-unit revenue from business with Nintendo to increase.
A Nintendo spokesman declined to comment.
MOVING ON UP: Taiwan improved in all four areas measured by the IMD, making its biggest leap, from 17th to sixth place, in economic performance Taiwan moved up three spots from last year to place eighth, its best performance since 2013, in the latest annual world competitiveness rankings, released yesterday by the International Institute for Management Development (IMD). Innovation, digitalization, welfare benefits and social cohesion are critical to economic performance, with Switzerland, Sweden, Denmark, the Netherlands and Singapore making up the top five on the list this year, the Switzerland-based institute said, after grading 64 countries and regions based on economic performance, infrastructure, and government and business efficiency. “Leading performers are characterized by varying degrees of investment in innovation, diversified economic activities and supportive public policy,” IMD
With the US opening up to travel, demand in Taiwan for US-bound flights has soared, pushing up ticket prices to most destinations in North America, tourism sources said. Fares for destinations in the US have risen dramatically since the middle of last month, and the trend is expected to continue in the coming months, as California on Tuesday lifted most social distancing and capacity limits put in place to contain the spread of COVID-19, ezTravel Co (易遊網) said in a statement yesterday. The travel agency forecast that the number of tickets sold this month is likely to be double or triple
‘MATTER OF SURVIVAL’: Vice Premier Liu He is to lead the development of ‘third-generation’ chips, a field not yet dominated by any nation or company Chinese President Xi Jinping (習近平) is renewing his years-long push to achieve technology self-sufficiency by tapping a top deputy to shepherd a key initiative aimed at helping domestic chipmakers overcome US sanctions. Chinese Vice Premier Liu He (劉鶴), Xi’s economic czar whose sprawling portfolio spans trade to finance and technology, has been tapped to spearhead the development of so-called “third-generation” chip development and capabilities, and is leading the formulation of a series of financial and policy supports for the technology, people with knowledge of the matter said. It is a nascent field that relies on newer materials and gear beyond traditional silicon,
OPPORTUNITY: The company aims to sell its product soon, as enterovirus vaccines are not available anywhere but China, where firms are only marketing their vaccines locally Medigen Vaccine Biologics Corp’s (高端疫苗) phase 3 clinical trials for an enterovirus 71 (EV71) vaccine completed the multi-regional, multi-central data “unblinding” yesterday, with the results, including safety, immunogenicity and efficacy, meeting its expectations. The company would compile a final analysis report as soon as possible, and apply for the new drug certificate from domestic and foreign drug authorities in the third quarter, Medigen said in a Taiwan Stock Exchange filing yesterday. Its phase 3 trials were conducted in Taiwan and Vietnam with 3,049 participants ranging from two months old to six years old, Medigen said. The company enrolled its first participant for